SLC12A8 and urinary bladder carcinoma: The invasive ability was 2.37 times of the control group (p < 0.01), while the migratory ability was 1.91 times of the control group (p < 0.01) (Figure 3i), illustrating that the invasive and migratory capacities of bladder cancer cells were enhanced by SLC12A8 upregulation.